SEC FORM 4
$13,194.80
Bolt Biotherapeutics, Inc. (BOLT)
Sale of 4,077 shares at $3.2364 per share.
Reporting Person Nemec Sarah · Officer Title Senior VP, Finance and PAO · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →